Lantheus Holdings, Inc. (LNTH) stock
LNTHNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 11/3012% above fair value
$102.00+0.20 (+0.20%)
Close on Nov 18, 2026Market cap $6.66BP/E 24.7Yield –
Lantheus net income
Net income is the profit left for shareholders after every expense, interest and tax.
Lantheus's net income for the twelve months ending Jun 30, 2026 was $275.31M, up 1.6% year over year. For fiscal 2025 it was $233.56M, down 25.2% from the year before. The highest annual figure on record is $326.66M in fiscal 2023.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $233.56M | -25.2% |
| FY2024 | Dec 31, 2024 | $312.44M | -4.4% |
| FY2023 | Dec 31, 2023 | $326.66M | +1063.9% |
| FY2022 | Dec 31, 2022 | $28.07M | – |
| FY2021 | Dec 31, 2021 | -$71.28M | – |
| FY2020 | Dec 31, 2020 | -$13.47M | -142.5% |
| FY2019 | Dec 31, 2019 | $31.67M | -21.8% |
| FY2018 | Dec 31, 2018 | $40.52M | -67.2% |
| FY2017 | Dec 31, 2017 | $123.39M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $75.03M | -4.7% |
| Q1 FY2026 | Mar 31, 2026 | $118.42M | +62.3% |
| Q4 FY2025 | Dec 31, 2025 | $54.09M | – |
| Q3 FY2025 | Sep 30, 2025 | $27.77M | -78.8% |
| Q2 FY2025 | Jun 30, 2025 | $78.76M | +26.9% |
| Q1 FY2025 | Mar 31, 2025 | $72.95M | -44.3% |
| Q4 FY2024 | Dec 31, 2024 | -$11.79M | -111.4% |
| Q3 FY2024 | Sep 30, 2024 | $131.09M | -0.7% |
| Q2 FY2024 | Jun 30, 2024 | $62.07M | -34.1% |
| Q1 FY2024 | Mar 31, 2024 | $131.07M | – |
| Q4 FY2023 | Dec 31, 2023 | $103.38M | – |
| Q3 FY2023 | Sep 30, 2023 | $131.96M | +115.5% |
| Q2 FY2023 | Jun 30, 2023 | $94.13M | +118.6% |
| Q1 FY2023 | Mar 31, 2023 | -$2.81M | -106.5% |
| Q4 FY2022 | Dec 31, 2022 | -$119.19M | – |
| Q3 FY2022 | Sep 30, 2022 | $61.23M | – |
| Q2 FY2022 | Jun 30, 2022 | $43.06M | – |
| Q1 FY2022 | Mar 31, 2022 | $42.96M | +376.9% |
| Q4 FY2021 | Dec 31, 2021 | -$40.22M | – |
| Q3 FY2021 | Sep 30, 2021 | -$13.42M | – |
| Q2 FY2021 | Jun 30, 2021 | -$26.66M | – |
| Q1 FY2021 | Mar 31, 2021 | $9.01M | +169.9% |
| Q4 FY2020 | Dec 31, 2020 | -$3.41M | -132.7% |
| Q3 FY2020 | Sep 30, 2020 | -$6.39M | -231.5% |
| Q2 FY2020 | Jun 30, 2020 | -$7.01M | -209.4% |
| Q1 FY2020 | Mar 31, 2020 | $3.34M | -66.5% |
| Q4 FY2019 | Dec 31, 2019 | $10.45M | -21.4% |
| Q3 FY2019 | Sep 30, 2019 | $4.86M | -47.6% |
| Q2 FY2019 | Jun 30, 2019 | $6.41M | -34.2% |
| Q1 FY2019 | Mar 31, 2019 | $9.95M | +21.2% |
| Q4 FY2018 | Dec 31, 2018 | $13.29M | -86.3% |
| Q3 FY2018 | Sep 30, 2018 | $9.27M | +8.7% |
| Q2 FY2018 | Jun 30, 2018 | $9.75M | -28.3% |
| Q1 FY2018 | Mar 31, 2018 | $8.21M | +98.4% |
| Q4 FY2017 | Dec 31, 2017 | $97.13M | +1894.8% |
| Q3 FY2017 | Sep 30, 2017 | $8.53M | +102.0% |
| Q2 FY2017 | Jun 30, 2017 | $13.60M | – |
| Q1 FY2017 | Mar 31, 2017 | $4.14M | – |
| Q4 FY2016 | Dec 31, 2016 | $4.87M | – |
| Q3 FY2016 | Sep 30, 2016 | $4.22M | – |
See a number that looks wrong?